The IL-17 Revolution: Redefining the Hidradenitis Suppurativa Treatment Paradigm
What is the impact of IL-17 antagonism on current HS care?
Hidradenitis Suppurativa (HS) has long been a domain of limited therapeutic options, largely dominated by TNF-alpha inhibitors. However, the emergence of IL-17 inhibitors represents a fundamental shift in treating moderate-to-severe cases. By targeting...